Rejecting ovarian cancer drug Olaparib is a major disappointment

NICE recently chose not to recommend the drug, despite the huge amounts of money that went into its development. Thankfully, other new research programmes are constantly making progress
Source: The Telegraph : Health Advice - Category: Consumer Health News Tags: Olaparib cancer treatment Judith Potts health cancer drug ovarian cancer Source Type: news